Skip to content

Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders

Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05566015
Acronym
CompaSchizo
Enrollment
0
Registered
2022-10-04
Start date
2022-09-26
Completion date
2023-07-01
Last updated
2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenic Spectrum Disorder, Selfcompassion, Treatment Adherence

Keywords

Treatment Adherence, Selfcompassion, schizophrenic spectrum disorder

Brief summary

Treatment adherence is defined by the World Health Organisation (WHO) as the extent to which the patient's history of therapeutic drug-taking coincides with the prescribed treatment. In patients suffering from psychiatrical diseases, especially in those who are suffering from schizophrenic spectrum disorders, the quality of treatment adherence has to be improved. Indeed, non adherance to anti-psychotic treatment increases the risk of hospitalization, of substance use, violent behaviour and of functionnal and cognitif impairment. Selfcompassion, which involves being touched by and open to one's own suffering and to heal oneself with kindness and without judgement and self-criticism has never beed studied as a possible factor infuencing treatment adherence. This study aims to evaluate if a link between selfcompassion and treatment adherence exists in patients suffering from schizophrenic spectrum disorders.

Interventions

OTHERquestionnaire

self-administered questionnaires as well as clinical assessment of schizophrenia symptoms and depression.

Sponsors

Crysalid center Clermont de l'Oise
CollaboratorUNKNOWN
CMP de Montataire
CollaboratorUNKNOWN
CMP de Chambly
CollaboratorUNKNOWN
CMP de Clermont de l'Oise
CollaboratorUNKNOWN
CMP de st Just en Chaussée
CollaboratorUNKNOWN
CMP de Senlis
CollaboratorUNKNOWN
CMP de Crepy en Valois
CollaboratorUNKNOWN
CMP de Pont St Maxence
CollaboratorUNKNOWN
CMP de Chantilly
CollaboratorUNKNOWN
CMP de Creil
CollaboratorUNKNOWN
Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients diagnosed with schizophrenia spectrum disorder ( ICD 10 and DSM 5 criteria) * stabilized (PANNS score under 80) * aged 18 or above * In case of tutor or curator, agreement of this person is requiered * psychiatrist who's following the patient agrees with the study

Exclusion criteria

* underage * non stabilized patient (PANSS score under 80 ) * patient suffering from toxic psychosis * difficulties to understand french or cognitive impairment which are making it to difficult to answer the different self-administered questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
Average level of self compassionone hourThe level of self compassion will be assessed with the french version of the Self-compassion scale developped and tested by K.Neff. Average scores for the Self-Compassion Scale are around 3.0 on the 1-5 Likert scale, a score of 1-2.5 indicates low self-compassion, 2.5-3.5 indicates moderate, and 3.5-5.0 is an indication of high self-compassion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026